## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_20 at 14.1% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($180.78)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Lam Research stock hits a record close after Citi spotlight — what LRCX investors watch next**
- Source: ts2.tech | 20260104T174900 | Bullish | Relevance: 100%
- Lam Research (LRCX) stock closed at a record high of $185.06, up 8.1% on Friday, following Citi's inclusion of the chip-tool maker on its Large Cap Recommended list for 2026. The rally was part of a broader surge in the semiconductor sector, with investors focusing on upcoming economic data and Lam's Q2 2026 earnings report scheduled for January 28. Technical indicators show the stock near its peak, with traders eyeing $180 as a key level, while potential risks include U.S. export controls and tariff uncertainties.

**2. Lam Research's (NASDAQ:LRCX) three-year earnings growth trails the fantastic shareholder returns**
- Source: Simply Wall Street | 20260104T121427 | Bullish | Relevance: 100%
- Lam Research Corporation (NASDAQ:LRCX) has seen its share price increase by 316% over three years, indicating fantastic shareholder returns. However, the company's compound earnings per share growth was 9.8% annually over the same period, suggesting the market's opinion of the business has improved beyond its earnings growth. When considering dividends, Lam Research's total shareholder return for the last three years was even higher at 329%.

**3. Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next**
- Source: ts2.tech | 20260103T161955 | Bullish | Relevance: 100%
- Lam Research stock (LRCX) surged over 8% on the first trading day of 2026, outperforming the semiconductor sector rally. This jump was fueled by positive policy headlines regarding U.S. chip-tool licensing for China operations. Investors are now focused on upcoming U.S. labor market data, further export rule developments, and the company's next earnings announcement.

**4. CWA Asset Management Group LLC Purchases 22,171 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20260105T100815 | Bullish | Relevance: 100%
- CWA Asset Management Group LLC significantly increased its stake in Lam Research Corporation by 87.2% in Q3, acquiring an additional 22,171 shares to hold a total of 47,597 shares valued at $6.37 million. Lam Research (NASDAQ:LRCX) exceeded Q3 earnings estimates with an EPS of $1.26 and revenue of $5.32 billion, and despite recent insider stock sales totaling approximately $14.9 million, analysts currently rate the stock as a "Moderate Buy" with a consensus target price of $161.21. The semiconductor company also announced a quarterly dividend and its Q2 2026 EPS guidance.

**5. GAM Holding AG Decreases Holdings in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20260103T130804 | Neutral | Relevance: 100%
- GAM Holding AG significantly reduced its stake in Lam Research Corporation by 16.4% in the third quarter, selling 23,600 shares and now holding 120,436 shares valued at $16.13 million. The semiconductor company recently beat quarterly earnings expectations with $1.26 EPS and $5.32 billion in revenue, and insiders have been net sellers in the past 90 days. Analysts currently have a "Moderate Buy" consensus rating for Lam Research with a target price of $161.21.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | UBS | $200 | $175 | +14% |
| 2025-12-18 | B. Riley Securi | $195 | $180 | +8% |
| 2025-12-17 | Mizuho | $200 | $170 | +18% |
| 2025-12-15 | Jefferies | $200 | $175 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | UBS | main | Buy |
| 2025-12-18 | B. Riley Securi | main | Buy |
| 2025-12-17 | Mizuho | main | Outperform |
| 2025-12-15 | Jefferies | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($2.00M) |
| Sells | 6 ($14.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $15M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +14%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +8.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 34.6x stretched relative to 16% growth. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (4 raises, avg +14%). Insider selling cluster ($14.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $245.6B |
| Beta | 1.78 |
| 52W Range | $56.32 - $198.36 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 34.6 |
| Current P/E | 40.2 |
| YoY Growth | 16.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 5.7% to 14.1% (+8.4% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (14.1% > 10.0%), caution on chasing. MRS_5 at 7.9% confirms short-term momentum alignment. AM_20 at 14.2% shows strong absolute momentum above own 20MA. Outperforming sector by 14.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.64), confirming momentum. RSI overbought at 72, risk of mean reversion. OFD pattern: +MUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 14.06% (CS: 98) | Strong |
| RSI_14 | 72.0 | Overbought |
| MACD Histogram | 1.64 | Bullish |
| vs SMA20 | 1.142x | Above |
| vs SMA50 | 1.208x | Above |
| vs SMA200 | 1.721x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $194.76
- **Stop Loss:** $180.78 (7.2% risk)
- **Target:** $208.74 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 82
- **Position Value:** $15,970.32
- **Portfolio %:** 15.97%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*